Immune Aspects of Biopharmaceuticals and Nanomedicines / (Record no. 69788)

000 -LEADER
fixed length control field 04567cam a2200781Ki 4500
001 - CONTROL NUMBER
control field 9781351399784
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220711211858.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180413s2018 si o 000 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780203731536
-- (e-book)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0203731530
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781351399784
-- (e-book ;
-- PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1351399780
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781351399777
-- (electronic bk. : EPUB)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1351399772
-- (electronic bk. : EPUB)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781351399760
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1351399764
-- (electronic bk. : Mobipocket)
082 04 - CLASSIFICATION NUMBER
Call Number 616.079
245 00 - TITLE STATEMENT
Title Immune Aspects of Biopharmaceuticals and Nanomedicines /
250 ## - EDITION STATEMENT
Edition statement First edition.
300 ## - PHYSICAL DESCRIPTION
Number of Pages 1 online resource :
490 1# - SERIES STATEMENT
Series statement Pan Stanford Series on Nanomedicine ;
520 2# - SUMMARY, ETC.
Summary, etc "The enormous advances in the immunology of biotherapeutics and nanomedicines in the past two decades have necessitated an authoritative and comprehensive reference that can be relied upon by immunologists, biomedical researchers, physicians, pharmaceutical and formulation scientists, clinicians, regulatory personnel, technology transfer officers, venture capitalists, and policy makers alike. This book provides a broad survey of various interconnected topics, all accomplished in a user?friendly format. The chapters are devoted to the immune stimulatory and suppressive effects of antibodies, peptides and other biopharmaceuticals, drug carrier liposomes, micelles, polymers, polymeric vesicles, dendrimers, carbon nanotubes, and other nanomedicines (with and without surface targeting ligands). The text discusses the state of the art in nanoparticle?formulated therapeutic and preventive vaccines along with their potential molecular mechanisms underlying immunogenicity. The latter phenomenon is addressed as an adverse effect of monoclonal antibodybased biopharmaceuticals and nanomedicines. Yet another adverse immune effect of monoclonals and nanomedicines, complement activation?related pseudoallergy (CARPA), is discussed in unprecedented detail in terms of occurrence, prediction, prevention, and mechanism. The range of the contributing authors accurately reflects the diverse and rapidly evolving fields of biotherapeutics, nanomedicines, nanoimmunology, and nanotoxicology. The books multidisciplinary and in?depth approach makes it a standard reference in this expansive and interdisciplinary field."--Provided by publisher.
700 1# - AUTHOR 2
Author 2 Bawa, Raj,
700 1# - AUTHOR 2
Author 2 Szebeni, Janos,
700 1# - AUTHOR 2
Author 2 Webster, Thomas J.,
700 1# - AUTHOR 2
Author 2 Audette, Gerald F.,
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://www.taylorfrancis.com/books/9781351399784
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://www.taylorfrancis.com/books/9780203731536
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks
264 #1 -
-- Singapore :
-- Pan Stanford Publishing,
-- 2018.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
588 ## -
-- OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Immunology.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical engineering.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Nanoscience.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Nanotechnology.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- HEALTH & FITNESS / Diseases / General.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Clinical Medicine.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Diseases.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Evidence-Based Medicine.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Internal Medicine.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Biotechnology
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Immunology
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- SCIENCE / Biotechnology

No items available.